# Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

> **NCT03143192** · PHASE2,PHASE3 · COMPLETED · sponsor: **Keyvan Koushan** · enrollment: 31 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **COMBINATION_PRODUCT:** Micropulse Laser
- **DEVICE:** Sham Laser

## Key facts

- **NCT ID:** NCT03143192
- **Lead sponsor:** Keyvan Koushan
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-08
- **Primary completion:** 2019-05-09
- **Final completion:** 2019-05-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03143192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03143192, "Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03143192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
